Remodeling of cardiolipin by phospholipid transacylation.
about
Human trifunctional protein alpha links cardiolipin remodeling to beta-oxidationMitochondrial targeting of electron scavenging antioxidants: regulation of selective oxidation vs random chain reactionsMitochondria targeting of non-peroxidizable triphenylphosphonium conjugated oleic acid protects mouse embryonic cells against apoptosis: role of cardiolipin remodelingMitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synucleinFormation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid speciesIdentification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1)Phospholipid scramblase-3 regulates cardiolipin de novo biosynthesis and its resynthesis in growing HeLa cellsAlterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics studyBarth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell StudiesLipid Acyl Chain Remodeling in YeastThe Role of Cardiolipin in Cardiovascular HealthMitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzinsDeacylation on the matrix side of the mitochondrial inner membrane regulates cardiolipin remodeling.Identification of a cardiolipin-specific phospholipase encoded by the gene CLD1 (YGR110W) in yeastTaz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth SyndromeYpr140wp, 'the yeast tafazzin', displays a mitochondrial lysophosphatidylcholine (lyso-PC) acyltransferase activity related to triacylglycerol and mitochondrial lipid synthesisMechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae TafazzinMonolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosisThe enzymatic function of tafazzinCardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagyMonolysocardiolipin: improved preparation with high yieldDietary macronutrients modulate the fatty acyl composition of rat liver mitochondrial cardiolipinsCardiolipin Interactions with ProteinsMass-spectrometric characterization of phospholipids and their primary peroxidation products in rat cortical neurons during staurosporine-induced apoptosisCardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and functionThe topology and regulation of cardiolipin biosynthesis and remodeling in yeastAgpat6--a novel lipid biosynthetic gene required for triacylglycerol production in mammary epitheliumA novel cardiolipin-remodeling pathway revealed by a gene encoding an endoplasmic reticulum-associated acyl-CoA:lysocardiolipin acyltransferase (ALCAT1) in mouseBacteria, yeast, worms, and flies: exploiting simple model organisms to investigate human mitochondrial diseasesLipidomics for studying metabolismCardiolipin, a critical determinant of mitochondrial carrier protein assembly and function.Dynamic simulation of cardiolipin remodeling: greasing the wheels for an interpretative approach to lipidomics.Loss of function of KRE5 suppresses temperature sensitivity of mutants lacking mitochondrial anionic lipidsA mathematical model for the determination of steady-state cardiolipin remodeling mechanisms using lipidomic data.Intrinsic mitochondrial membrane potential and associated tumor phenotype are independent of MUC1 over-expression.The increase of cell-membranous phosphatidylcholines containing polyunsaturated fatty acid residues induces phosphorylation of p53 through activation of ATR.Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity.Genetic ablation of calcium-independent phospholipase A2gamma leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotypeBarth syndrome is associated with a cognitive phenotype.Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure.
P2860
Q21090849-DE5685EC-6CAC-47FB-86A9-E3C8DCD23CCAQ23923177-7B5CDE52-038B-4A0A-A61A-BD531475C227Q23924135-6E9C8418-D5D6-445C-8B59-160739BE9B39Q24537310-C76EAAEA-8CF0-43CC-A503-2558384CA126Q24647646-457DE9E5-5D69-44A6-A5AD-E62974F7918EQ24652109-9187EC14-28F1-41A1-9E28-C8A09801BD64Q24671951-C9878686-F457-4E43-8AC4-A4AB6ACC058CQ24678475-90F23303-CFE4-4C86-AB10-25C9819CF6C1Q26772690-89BAF04B-A8F2-461F-A2D4-A260A46ECE11Q26773169-8205F0A4-53E5-4C1A-AD9D-FAF1E4866672Q26798052-690BE62D-FF38-4E62-8CD9-E15692ACFA2FQ27930348-CCE77C53-785A-43AC-852B-0D7BAF350B01Q27932861-DC3703ED-3DED-4A0D-9E43-484E01625565Q27934941-3488ED5B-2785-436B-A588-9A5ED329CF00Q27936928-C7F2AB98-ED87-4952-8CF7-05EDAE970C2BQ27938893-5F9E10B6-BBD7-4AA6-9660-B1D003D44E66Q27939541-B00F5623-7993-4ED7-BCD3-766FA9D0E697Q28243113-96A89F17-AA52-4F64-B46A-9E4DB91F5593Q28272001-CB51F159-F0E7-4B93-80E6-E7DD08905BC4Q28383403-736A126C-52F8-4EEC-AFF9-05608140C62CQ28385844-5512D739-B544-44D4-8A89-9FE75ED23F0AQ28388441-DE3FA532-59CF-4318-B568-06AF7AD44CE7Q28389105-52E6AF8F-7713-4D96-9A2E-9EAD493C01C8Q28391477-3A649674-3B72-43FB-B6B1-35CA85EBD0D4Q28395178-6A87B82C-CF70-4432-8C8C-81B2729D2EF1Q28397368-98BB59DD-3365-47EB-8976-4FA582C26AC6Q28513321-966E2096-E4E5-4641-B355-3DE2F1851BF2Q28593824-3F08E1E3-4DA2-456C-8520-24DCA11963BAQ28708978-D3E65CB2-2772-4654-8135-2D07C089D360Q28802472-7A2A0D6B-E0D2-42DA-B93F-2B6A054DC63DQ30376858-3564758D-4379-40F9-8194-0665BEF3BDBFQ30495485-7D1BE82F-906A-46BF-8F4D-DDA05D86B737Q33763830-47193C80-AF8C-4198-A040-A267FD2073B8Q33939499-F05775BF-F079-4544-8A91-46BDFF13E353Q34038061-517356B4-3402-4729-A502-D79B8790D74DQ34041919-AE74305B-3EFF-4FA4-981D-1F78341839AAQ34072371-17F4E6A0-9859-4F15-B7C7-9C56227F0B54Q34304761-EDBF434C-19DE-42DF-A0BB-1D342D87D84DQ34577468-BC2A531E-44E3-4DA0-A8B8-47CF0B496B88Q34617967-C50E5136-3696-4A6C-A05C-F3B3C255608B
P2860
Remodeling of cardiolipin by phospholipid transacylation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Remodeling of cardiolipin by phospholipid transacylation.
@en
Remodeling of cardiolipin by phospholipid transacylation.
@nl
type
label
Remodeling of cardiolipin by phospholipid transacylation.
@en
Remodeling of cardiolipin by phospholipid transacylation.
@nl
prefLabel
Remodeling of cardiolipin by phospholipid transacylation.
@en
Remodeling of cardiolipin by phospholipid transacylation.
@nl
P2860
P356
P1476
Remodeling of cardiolipin by phospholipid transacylation
@en
P2093
Richard I Kelley
P2860
P304
51380-51385
P356
10.1074/JBC.M307382200
P407
P577
2003-10-09T00:00:00Z